Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash from Operations (2020 - 2025)

Historic Cash from Operations for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$1.9 million.

  • NeuroPace's Cash from Operations fell 790.07% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.3 million, marking a year-over-year increase of 145.45%. This contributed to the annual value of -$17.9 million for FY2024, which is 889.29% up from last year.
  • NeuroPace's Cash from Operations amounted to -$1.9 million in Q3 2025, which was down 790.07% from -$2.1 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Cash from Operations registered a high of -$1.8 million during Q3 2024, and its lowest value of -$11.4 million during Q1 2022.
  • For the 5-year period, NeuroPace's Cash from Operations averaged around -$5.8 million, with its median value being -$5.9 million (2021).
  • Per our database at Business Quant, NeuroPace's Cash from Operations tumbled by 9204.85% in 2022 and then skyrocketed by 6679.18% in 2023.
  • Over the past 5 years, NeuroPace's Cash from Operations (Quarter) stood at -$8.2 million in 2021, then grew by 3.98% to -$7.9 million in 2022, then surged by 58.08% to -$3.3 million in 2023, then tumbled by 43.87% to -$4.7 million in 2024, then skyrocketed by 59.74% to -$1.9 million in 2025.
  • Its Cash from Operations was -$1.9 million in Q3 2025, compared to -$2.1 million in Q2 2025 and -$7.5 million in Q1 2025.